Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma. [electronic resource]
Producer: 20160315Description: 953-64 p. digitalISSN:- 1523-5866
- Anilides -- pharmacology
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Brain Stem Neoplasms -- drug therapy
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Child
- Child, Preschool
- Dasatinib -- pharmacology
- Female
- Glioma -- drug therapy
- Humans
- Male
- Neoplasm Invasiveness -- prevention & control
- Pons -- metabolism
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-met -- metabolism
- Pyridines -- pharmacology
- Receptor, Platelet-Derived Growth Factor alpha -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.